• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist

    6/19/26 3:00:00 AM ET
    $RAAQ
    $TXG
    $ILMN
    $INTC
    Blank Checks
    Finance
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $RAAQ alert in real time by email
    • Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies.
    • De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications.

    IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (NASDAQ:RAAQ).

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/

    From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer.

    From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer.

    Ciesla, an experienced deep tech executive with more than 25 years delivering products across multiple industries from startups to Fortune 500 companies, will advance IQM's technology strategy and drive its implementation into systems and products. De Vega, meanwhile, will be responsible for ensuring scientific feasibility and system-level consistency across IQM's technology.

    "Ciesla's track record of scaling complex instrumentation platforms and building world-class R&D organizations makes him an exceptional addition to our leadership team," said Jan Goetz, CEO and Co-founder of IQM Quantum Computers. "As we accelerate our path toward fault-tolerant quantum computing, his experience integrating hardware and software systems at scale will be invaluable. I also want to thank Inés for her outstanding contributions over the years, and I am pleased she will continue to shape our technology roadmap in her new role."

    Ciesla is an accomplished innovator and product development leader with a proven track record and is an inventor of more than 100 patents and patent applications. He most recently served as Vice President of Engineering at 10x Genomics (NASDAQ:TXG) and previously held leadership roles at companies including Illumina (NASDAQ:ILMN) Lumentum (NASDAQ:JDSU), Intel (NASDAQ:INTC), and Tactus Technology.

    He also has significant board experience, serving on the Board of Directors of Lightwave Logic, Inc., (NASDAQ:LWLG) complemented by an academic background that includes a PhD in Physics from Heriot-Watt University.

    "IQM has established itself as an industry leader in quantum computing through a combination of technological excellence, real-world deployments, and disciplined execution. What attracted me to the company is its commitment to building production-grade quantum systems that customers can own, operate, and build value on — not just promises of what quantum could one day do," said Craig Ciesla.

    These appointments come as IQM continues to scale its technology roadmap and operations as a fully vertically integrated quantum computing company — operating its own chip factory and assembly line, and having sold 23 quantum computers to date, more than any other manufacturer.

    "Over the past years, I have seen first-hand how IQM has evolved from an ambitious deep-tech venture into a company delivering quantum computers to some of the world's leading research institutions and supercomputing centers," said De Vega. "I look forward to further contributing to the company's growth trajectory."

    Throughout her career, she has led a team responsible for developing and implementing quantum algorithms across a wide range of quantum computing applications, while developing advanced tools to tackle errors in quantum computers.

    Furthermore, she has been a researcher in several academic institutions, such as the Max Planck of Quantum Optics, the University of Ulm, and the Ludwig Maximilian University of Munich, where she is currently associated to the department of Theoretical Nanophysics.

    IQM is nearing its Nasdaq listing through a planned merger with Real Asset Acquisition Corp. (NASDAQ:RAAQ). The transaction has gained momentum since February, with an upsized PIPE of $146 million in early June after Finnish pension insurer Ilmarinen joined existing institutional investors.

    About IQM Quantum Computers

    IQM Quantum Computers is a global leader in superconducting quantum computers, delivering full-stack quantum computers and cloud platform access to research institutions, universities, high-performance computing centers, national laboratories and enterprises worldwide. IQM's on-premises deployment model gives customers direct ownership and control of their quantum infrastructure. Founded in 2018, headquartered in Finland with major operations in Munich, it has over 400 employees. IQM operates across Europe, Asia, and North America. IQM filed an F-4 registration statement with the SEC, which has since been declared effective, with the intention to become the first publicly listed European quantum company on Nasdaq Global Exchange in the U.S by merging with Real Asset Acquisition Corp. (NASDAQ:RAAQ).

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260619693929/en/

    IQM Media contact:

    Email: press@meetiqm.com

    Mobile: +358 (0) 50 479 0845

    Get the next $RAAQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RAAQ
    $TXG
    $ILMN
    $INTC

    CompanyDatePrice TargetRatingAnalyst
    Illumina Inc.
    $ILMN
    6/26/2026$185.00Mkt Perform
    Bernstein
    Intel Corporation
    $INTC
    6/25/2026$150.00Neutral
    Goldman
    Intel Corporation
    $INTC
    6/11/2026$135.00Underperform → Buy
    BofA Securities
    Illumina Inc.
    $ILMN
    6/10/2026$185.00Neutral → Overweight
    Analyst
    Intel Corporation
    $INTC
    5/26/2026Outperform → Market Perform
    Northland Capital
    Intel Corporation
    $INTC
    5/18/2026$105.00 → $140.00Buy
    The Benchmark Company
    Intel Corporation
    $INTC
    5/18/2026$95.00 → $130.00Buy
    Citigroup
    Illumina Inc.
    $ILMN
    5/15/2026$170.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $RAAQ
    $TXG
    $ILMN
    $INTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gottlieb Scott bought $23,562 worth of shares (200 units at $117.81), increasing direct ownership by 2% to 12,723 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    2/11/26 4:04:54 PM ET
    $ILMN
    Medical Specialities
    Health Care

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Director Gottlieb Scott bought $61,065 worth of shares (500 units at $122.13), increasing direct ownership by 4% to 12,523 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    11/5/25 4:05:20 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $RAAQ
    $TXG
    $ILMN
    $INTC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intel and Fortinet Collaborate to Advance Cybersecurity Innovation and Strengthen Global Supply Chain Resilience

    Intel Corporation (NASDAQ:INTC) and Fortinet (NASDAQ:FTNT), today announced a strategic collaboration to develop Fortinet Security Processor 6 (SP6). Expanding a long-standing relationship between the two companies, this collaboration combines Fortinet’s proprietary, purpose-built security processor expertise with Intel’s advanced design, packaging, and manufacturing capabilities to accelerate and strengthen SP6 development. This work will also help to improve the resilience and diversity of Fortinet’s global supply chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260721378476/en/ "As organizations face a rapidly evolving t

    7/21/26 9:00:00 AM ET
    $INTC
    $FTNT
    Semiconductors
    Technology
    Computer peripheral equipment

    Mobileye to Supply Cloud-Enhanced ADAS for Select Future Stellantis Vehicles

    From 2027, select Stellantis vehicles will integrate Mobileye’s REM Road Experience Management™ technology, increasing hands-free driving availability and performance through crowdsourced intelligence. Mobileye, a global leader in advanced driving assistance and autonomous vehicle technology, announced today that its Cloud-Enhanced Advanced Driver Assist™ technology will be integrated into select future Stellantis vehicles expected in 2027, supporting safety and convenience features through advanced crowdsource intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260721288166/en/Illustration: Mobileye Stellantis joins

    7/21/26 7:00:00 AM ET
    $MBLY
    $INTC
    Computer Software: Prepackaged Software
    Technology
    Semiconductors

    Illumina expands Billion Cell Atlas program with new AI drug developers

    Partners will use unprecedented data scale to advance more precise medicines to approvalSAN DIEGO, July 16, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug developer Formation Bio. As leaders in AI-driven drug discovery, design, and development, alliance members will use the unprecedented scale of Illumina's genome-wide perturbation data as infrastructure for the next generation of therapeutics. "We are building the cell atlas to address key bottlenecks across the drug discovery and development continuum," said Rami Mehio, senior vice president and

    7/16/26 12:00:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $RAAQ
    $TXG
    $ILMN
    $INTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Mark A. returned 25,000 units of Class A Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Real Asset Acquisition Corp. (0002052161) (Issuer)

    7/16/26 5:12:41 PM ET
    $RAAQ
    Blank Checks
    Finance

    Director Raaq Sponsor Llc returned 5,615,000 units of Class A Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Real Asset Acquisition Corp. (0002052161) (Issuer)

    7/16/26 5:12:28 PM ET
    $RAAQ
    Blank Checks
    Finance

    Director Neal Robert returned 25,000 units of Class A Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Real Asset Acquisition Corp. (0002052161) (Issuer)

    7/16/26 5:12:13 PM ET
    $RAAQ
    Blank Checks
    Finance

    $RAAQ
    $TXG
    $ILMN
    $INTC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $RAAQ
    $TXG
    $ILMN
    $INTC
    SEC Filings

    View All

    Bernstein resumed coverage on Illumina with a new price target

    Bernstein resumed coverage of Illumina with a rating of Mkt Perform and set a new price target of $185.00

    6/26/26 9:21:34 AM ET
    $ILMN
    Medical Specialities
    Health Care

    Goldman initiated coverage on Intel with a new price target

    Goldman initiated coverage of Intel with a rating of Neutral and set a new price target of $150.00

    6/25/26 8:39:07 AM ET
    $INTC
    Semiconductors
    Technology

    Intel upgraded by BofA Securities with a new price target

    BofA Securities upgraded Intel from Underperform to Buy and set a new price target of $135.00

    6/11/26 8:00:56 AM ET
    $INTC
    Semiconductors
    Technology

    Lightwave Logic Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Lightwave Logic, Inc. (0001325964) (Filer)

    7/20/26 9:00:14 AM ET
    $LWLG
    Containers/Packaging
    Industrials

    SEC Form 15-12G filed by Real Asset Acquisition Corp.

    15-12G - Real Asset Acquisition Corp. (0002052161) (Filer)

    7/13/26 4:01:06 PM ET
    $RAAQ
    Blank Checks
    Finance

    Real Asset Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits

    8-K - Real Asset Acquisition Corp. (0002052161) (Filer)

    7/8/26 5:20:15 PM ET
    $RAAQ
    Blank Checks
    Finance

    $RAAQ
    $TXG
    $ILMN
    $INTC
    Leadership Updates

    Live Leadership Updates

    View All

    Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer

    New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technologySAN DIEGO, July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of Mike Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie Coletti as Chief Legal Officer, effective August 3, 2026. The appointments add experienced leaders to Illumina's Executive Leadership Team as the company continues advancing its strategy, serving customers, driving growth, and delivering on its mission to improve human health around the world."We are excited to welcome Mike and Julie to Illumina," said Jacob Thaysen, chief executive officer of Illumina. "Mik

    7/9/26 9:05:00 AM ET
    $ILMN
    Medical Specialities
    Health Care

    Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors

    Eli Lilly and Company's Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina's BoardSAN DIEGO, June 23, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026. Dr. Skovronsky brings extensive experience in drug discovery, clinical development and translational medicine, which are areas directly relevant to Illumina's work advancing genomics and multiomics platforms. "Dan brings a rare combination of scientific expertise, innovation leadership, and healthcare

    6/23/26 9:05:00 AM ET
    $ILMN
    Medical Specialities
    Health Care

    IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist

    Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a me

    6/19/26 3:00:00 AM ET
    $RAAQ
    $TXG
    $ILMN
    Blank Checks
    Finance
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $RAAQ
    $TXG
    $ILMN
    $INTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    11/12/24 3:59:44 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $RAAQ
    $TXG
    $ILMN
    $INTC
    Financials

    Live finance-specific insights

    View All

    10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026

    PLEASANTON, Calif., July 15, 2026 /PRNewswire/ -- 10x Genomics, Inc. (NASDAQ:TXG), the life science technology leader focused on accelerating science and advancing human health, announced it will report financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 6, 2026. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

    7/15/26 4:05:00 PM ET
    $TXG
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

    SAN DIEGO, July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the second quarter 2026 following the close of market on Thursday, July 30, 2026. On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Conference Call DetailsThe conference call will begin at 1:30 pm Pacific Time (4:30 pm Eastern Time) on Thursday, July 30, 2026. Interested parties may access the live webcast via the Investor Info section of Illumina's we

    7/9/26 4:05:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Mobileye Announces Timing of its Second Quarter 2026 Results

    Mobileye Global Inc. (NASDAQ:MBLY) ("Mobileye") today announced that it will release its financial results for the second quarter 2026 on Thursday, July 23rd, 2026, before market open. Mobileye will host a conference call at 8:00am ET (3:00pm IT) to review its results and provide a general business update. The call will be hosted by Professor Amnon Shashua, CEO, Moran Shemesh Rojansky, CFO, Nimrod Nehushtan, EVP – Business Development and Strategy, and Dan Galves, CCO. The conference call will be accessible live via a webcast on Mobileye’s investor relations site, which can be found at https://ir.mobileye.com, and a replay of the webcast will be made available shortly after the event’s co

    7/9/26 7:30:00 AM ET
    $MBLY
    $INTC
    Computer Software: Prepackaged Software
    Technology
    Semiconductors